Drug Patents owned by Taro Pharms

1. List of Pliaglis drug patents

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US10603293 TARO PHARMS Solid-forming local anesthetic formulations for pain control
Jan, 2031

(7 years from now)

US10350180 TARO PHARMS Solid-forming local anesthetic formulations for pain control
Jan, 2031

(7 years from now)

US10751305 TARO PHARMS Solid-forming topical formulations for pain control
Jan, 2031

(7 years from now)

Drugs and Companies using LIDOCAINE; TETRACAINE ingredient

Market Authorisation Date: 29 June, 2006

Treatment: NA

Dosage: CREAM;TOPICAL

More Information on Dosage

PLIAGLIS family patents

8

United States

1

Brazil

1

Canada

1

Mexico

1

Australia

1

China

1

European Union

2. List of Topicort drug patents

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US8715624 TARO PHARMS Stable liquid desoximethasone compositions with reduced oxidized impurity
May, 2026

(3 years from now)

US8277780 TARO PHARMS Stable liquid desoximethasone compositions with reduced oxidized impurity
Sep, 2028

(5 years from now)

Drugs and Companies using DESOXIMETASONE ingredient

Market Authorisation Date: 11 April, 2013

Treatment: Treatment of plaque psoriasis in patients 18 years of age or older

Dosage: SPRAY;TOPICAL

How can I launch a generic of TOPICORT before it's patent expiration?
More Information on Dosage

TOPICORT family patents

5

United States

1

Israel

1

Canada

1

European Union

900+ leading pharmaceutical companies are staying up-to-date with drug patents through Pharsight

Join them to stay ahead in capturing the next drug going generic

Other things you might be interested in